{"slideshow_credits": null, "snippet": "Myriad Genetics and a specialist in genetics discuss the BRCA test that led to Angelina Jolie&#8217;s mastectomy.", "abstract": null, "section_name": "Opinion", "print_page": "20", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/05/17/opinion/genetic-testing-for-women-at-risk-of-cancer.html", "lead_paragraph": "Myriad Genetics and a specialist in genetics discuss the BRCA test that led to Angelina Jolie&#8217;s mastectomy.", "headline": {"main": "Genetic Testing for Women at Risk of Cancer", "print_headline": "Genetic Testing for Women at Risk of Cancer", "content_kicker": "Letters", "kicker": "Letters"}, "_id": "5195867e40e9ec457e2a1d07", "word_count": "290", "multimedia": [], "pub_date": "2013-05-17T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Jolie, Angelina", "name": "persons", "is_major": "N", "rank": "1"}, {"value": "Genetics and Heredity", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Breast Cancer", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Mastectomy", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Myriad Genetics Inc", "name": "organizations", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}